Global epidemiology of stroke and access to acute ischemic stroke interventions
V Saini, L Guada, DR Yavagal - Neurology, 2021 - AAN Enterprises
Purpose of the Review To provide an up-to-date review of the incidence of stroke and large
vessel occlusion (LVO) around the globe, as well as the eligibility and access to IV …
vessel occlusion (LVO) around the globe, as well as the eligibility and access to IV …
Ischemic stroke
SK Feske - The American journal of medicine, 2021 - Elsevier
Ischemic Stroke - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals &
Books Search RegisterSign in View PDF Download full issue Search ScienceDirect Elsevier The …
Books Search RegisterSign in View PDF Download full issue Search ScienceDirect Elsevier The …
Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy
Background Tenecteplase is an effective thrombolytic agent for eligible patients with stroke
who are treated within 4.5 hours after the onset of stroke. However, data regarding the …
who are treated within 4.5 hours after the onset of stroke. However, data regarding the …
Reteplase versus alteplase for acute ischemic stroke
S Li, HQ Gu, H Li, X Wang, A Jin, S Guo… - … England Journal of …, 2024 - Mass Medical Soc
Background Alteplase is the standard agent used in early reperfusion therapy, but
alternative thrombolytic agents are needed. The efficacy and safety of reteplase as …
alternative thrombolytic agents are needed. The efficacy and safety of reteplase as …
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
Background There is increasing interest in replacing alteplase with tenecteplase as the
preferred thrombolytic treatment for patients with acute ischaemic stroke. We aimed to …
preferred thrombolytic treatment for patients with acute ischaemic stroke. We aimed to …
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
E Berge, W Whiteley, H Audebert… - European stroke …, 2021 - journals.sagepub.com
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies
A Jurcau, A Simion - International journal of molecular sciences, 2021 - mdpi.com
Its increasing incidence has led stroke to be the second leading cause of death worldwide.
Despite significant advances in recanalization strategies, patients are still at risk for …
Despite significant advances in recanalization strategies, patients are still at risk for …
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Ischemic stroke caused by arterial occlusion is the most common type of stroke, which is
among the most frequent causes of disability and death worldwide. Current treatment …
among the most frequent causes of disability and death worldwide. Current treatment …
Noncontrast computed tomography vs computed tomography perfusion or magnetic resonance imaging selection in late presentation of stroke with large-vessel …
Importance Advanced imaging for patient selection in mechanical thrombectomy is not
widely available. Objective To compare the clinical outcomes of patients selected for …
widely available. Objective To compare the clinical outcomes of patients selected for …
Management of acute ischemic stroke
F Herpich, F Rincon - Critical care medicine, 2020 - journals.lww.com
Objectives: Concise “synthetic” review of the state of the art of management of acute
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …